Podcasts about hiv std

On this episode of EquiTEA, our special guest host, DuJuan James has the chance to speak with Dr. Carlos Calderon, the Medical Director for the HIV/STD Early Intervention Program at Riverside University Health System – Public Health. In recognition of World AIDS Day, they discuss the significance of this awareness day, highlighting the importance of continued efforts in the fight against HIV. The discussion spans from the diverse range of HIV symptoms and the importance of regular testing, as well as addressing barriers to care.  To get connected with HIV/STD resources, please visit:  HIV Care | Riverside University Health System 

Join LaTangela as she chats with Metro Health Baton Rouge on the #TanLine Ray Charles Williams, Sr. and ScoSax is giving  us the #InsideScoop on an amazing event hitting the capital city. Saturday, September 14th @ Manship Theater 100 Lafayette St. Baton Rouge, La. Doors open @ 6 Showtime @ 7:30 Metro Health offers free HIV/STD testing/COVID testing/Vaccines for RSV & FLU and MORE. 950 Lori Burgess Avenue Baton Rouge, La. 70802 RADIO -  WEMX- Baton Rouge, La. Mon-Fri 10a.m.-3p.m.CST KTCS - Beaumont, Tx. Mon-Fri 3-8 CST WWO -  YouTube - #LaTangelaFay Podcast - ALL digital platforms - #iTunes #Spotify #WEMX #WAFB+ www.LaTangela.comSee omnystudio.com/listener for privacy information.

As we sit down with the remarkable Atlantis Narcisse, her story unfolds, revealing the heart and soul she pours into Save Our Sisters United and her crucial role as a house mother. This week's conversation is nothing short of inspiring as we honor her nomination for Grand Marshal at Houston's Pride 365 Parade and delve into her commitment to offering stigma-free spaces for HIV/STD testing. Witness a powerful reflection on the importance of Atlantis's visibility as a black trans woman over 50, leaving an indelible mark on Houston's LGBTQ+ community.The air buzzes with anticipation for the Annual Walk to End HIV, where we come together in an expression of support and unity. Atlantis shares with us the vibrant ways the community participates, from the whimsy of unicycling to the charm of a dog dressing contest. The conversation takes a poignant turn as we remember those we've lost to AIDS and celebrate the progress in HIV treatment and housing as a cornerstone of healthcare. Atlantis's voice carries the weight and warmth of experience as she reminisces about the evolution of support services like the Stone Soup food pantry and the declining young attendance at Camp Hope, a testament to advancements in HIV prevention.The episode takes a creative twist with Alan Cumming, who offers an exclusive glimpse into his show "Alan Cumming Is Not Acting His Age," a captivating blend of storytelling, music, and musings on the art of growing older with flair. We then transition to the sobering story of the 1963 16th Street Baptist Church bombing, reimagined in the powerful play "Tide," with insights from actor Jason Carmichael and director Bruce Lumpkin. The narrative comes full circle as we round out the episode with global LGBTQ+ rights updates, highlighting triumphs and acknowledging hurdles in the universal quest for equality. Remember to join us on our new journey as a home-produced podcast, where we continue to amplify these vital conversations.Queer Voices airs in Houston Texas on 90.1FM KPFT and is heard as a podcast here. Queer Voices hopes to entertain as well as illuminate LGBTQ issues in Houston and beyond. Check out our socials at:https://www.facebook.com/QueerVoicesKPFT/ andhttps://www.instagram.com/queervoices90.1kpft/

लैंगिक आजार म्हणजे फक्त HIV/ AIDS का?इतर लैंगिक आजारांचे symptoms काय आहेत?STD किंवा STI म्हणजे नेमकं काय? STD/STI रिकव्हर होऊ शकतात का ? लैंगिक आजारांचा मानसिक स्वास्थ्यावर कसा परिणाम होतो? सगळेच लैंगिक आजार जीवघेणे असतात का? अश्या अनेक शंकांचं निरसन करण्यासाठी आपण चर्चा केली आहे डॉ.विनय कुलकर्णी (प्रयास अमृता क्लिनिक) ह्यांच्याशी. Credits Guests: Dr.Vinay Kulkarni (Prayas Amruta Clinic)Host: Omkar Jadhav Creative Producer: Shardul KadamEdit: Shrutika Mulay Edit Supervisor: Tanwee Paranjpe Edit Assistant: Mohit UbheIntern: Sohan Mane, Mandar AloneSocial Media Intern: Sonali Gokhale Connect with us: Twitter: https://twitter.com/amuk_tamukInstagram: https://www.instagram.com/amuktamuk/Facebook: https://www.facebook.com/amuktamukpodcastsSpotify: Khuspus  #AmukTamuk #MarathiPodcasts #Khuspus

When Melinda Joyner became a single mother as a young teenager, she took the experience as an opportunity to grow and help others.  As a result of understanding the difficult task of being a single mother, Melinda created a safe community of assistance and resources for other young single mothers in her community of Jackson, MS. She organized many events in the community to provide education and resources, and to tell other young mom's her story, to serve as a beacon of hope.    Underlying all of this is Melinda's strong belief that we all have a MORE- that thing that we are good at, adds value to this world, and lights us up.  Melinda found her MORE after years of working as a Rape Crisis Counselor for Catholic Charities, a crisis pregnancy counselor, and an HIV/STD counselor/educator.  When her grown kids were off to college, Melinda decided to return to school as well, where she ultimately obtained her Master's in Social Work.   Currently, Melinda is working as a Social Worker in the emergency department of a busy community hospital in San Francisco. Her goal is to continue to assist individuals to grow and evolve into the person they may have dreamed of or, due to trauma and circumstances, the person they never fathomed.   Melinda came to know Dr. Rak when she sought out his assistance in taking control of her health.  To that end, we discuss Melinda's relationship with food and her body, and how her view of her health has changed in the past few years.     This episode is a powerful one, and it really speaks to the power of having intention in our lives and manifesting our full potential.    Have a question or comment for Dr. Rak and Po?  You can submit them on our website at thehealthfeast.com  Disclaimer: The Health Feast is provided for educational and informational purposes only and does not constitute providing medical advice or professional services. As with any changes affecting your health, we recommend and encourage you to consult your medical doctor or other qualified healthcare professionals before embarking on this journey.  The opinions expressed are our own and do not necessarily reflect the opinions of our employers.

Today, she is the Founder and CEO of Moxley Public Health Consulting, but her career in public health began two decades ago as a health educator and program coordinator focused on HIV/STD prevention at the GO GIRL! Program in Bronx, New York. Ingrained in Stephanie's work is her love for collaboration, which not only improves the health and lives of the people she works with but makes her work more fun too! In this episode, we take a look at her fascinating journey into consulting, who her ideal client is, and what a community needs assessment entails. We also discuss her evidence-based, data-driven practices and how her understanding of public health and epidemiology has enabled her to have a greater impact, plus so much more! PHEC Podcast Show Notes

Peer support is an often ignored option in the treatment of schizophrenia. However, connecting with people who have lived similar experiences and are trained to share their knowledge, mention the things that they've gone through, and offer emotional, social and even practical support can be inspiring to someone learning to manage their schizophrenia. Sometimes it is as simple as knowing you are not alone. Hosts Rachel Star Withers and Gabe Howard explore ways that peer support can help people with schizophrenia. Juliet C. Dorris-Williams, Executive Director of The P.E.E.R. Center in Columbus, Ohio, joins to discuss what a huge impact a connection with a peer supporter can have. To learn more - or read the transcript - please visit the official episode page. Guest Bio Juliet C. Dorris-Williams is the Executive Director of The P.E.E.R. Center in Columbus, Ohio. The P.E.E.R. Center is a nonprofit drop-in wellness, recovery, and support center. Like each of the staff members, Juliet is living in long-term recovery. She spent more than 2 decades working in state government (TN, IN, and OH) providing administrative oversight for HIV/STD prevention, minority health, alcohol and other drug abuse prevention programs, as well as direct client services in multiple social service settings. Juliet is the board treasurer of OhioPRO — Ohio Peer Recovery Organizations, a statewide organization dedicated to advocating for peer recovery organizations, and is a member of the Recovery Ohio Advisory Council, appointed by Gov. Mike DeWine. She has a BS in Psychology from Indiana State University, an MSW from the Indiana University School of Social Work at Indianapolis, and is an independently licensed social worker supervisor and Ohio Peer Supporter. Juliet is a published author and a podcast host. Inside Schizophrenia Podcast Host Rachel Star Withers creates videos documenting her schizophrenia, ways to manage and let others like her know they are not alone and can still live an amazing life. She has written Lil Broken Star: Understanding Schizophrenia for Kids and a tool for schizophrenics, To See in the Dark: Hallucination and Delusion Journal. Fun Fact: She has wrestled alligators. To learn more about Rachel, please visit her website, RachelStarLive.com. Inside Schizophrenia Co-Host Gabe Howard is an award-winning writer and speaker who lives with bipolar disorder. He is the author of the popular book, "Mental Illness is an Asshole and other Observations," available from Amazon; signed copies are also available directly from the author. Gabe makes his home in the suburbs of Columbus, Ohio. He lives with his supportive wife, Kendall, and a Miniature Schnauzer dog that he never wanted, but now can't imagine life without. To learn more about Gabe, please visit his website, gabehoward.com.

Demetre Daskalakis, deputy coordinator of the White House national monkeypox response, and Jeremy Youde, dean of the College of Arts, Humanities, and Social Sciences at the University of Minnesota Duluth, discuss the emergence of monkeypox and other diseases, international responses, and messaging around health issues that especially affect the LGBTQ+ community. Jennifer Nuzzo, senior fellow for global health at CFR, moderates. Learn more about CFR's Religion and Foreign Policy Program. FASKIANOS: Thank you, and welcome to the Council on Foreign Relations Social Justice Webinar series. The purpose of this series is to explore social justice issues and how they shape policy at home and abroad through discourse with members of the faith community. I'm Irina Faskianos, vice president of the National Program and Outreach here at CFR. As a reminder, this webinar is on the record, and it will be made available on CFR's website, CFR.org, and on the iTunes podcast channel, “Religion and Foreign Policy.” As always, CFR takes no institutional positions on matters of policy. We're delighted to have Jennifer Nuzzo, senior fellow for global health at CFR, to moderate today's discussion on infectious diseases. Dr. Nuzzo is a senior fellow for global health here at CFR. She's also a professor of epidemiology and the inaugural director of the Pandemic Center at Brown University's School of Public Health. Her work focuses on global health security, public health preparedness and response, and health systems resilience. In addition to her research, she directs the Outbreak Observatory, which conducts operational research to improve outbreak preparedness and response. And she advises national governments, and for-profit and non-profit organizations on pandemic preparedness and response, and worked tirelessly during the COVID pandemic to advise and tell people what was going on, to the extent that we knew, as we made our way through this two-and-a-half-year pandemic. So, Jennifer, I'm going to turn it over to you to introduce our speakers. NUZZO: Great. Thank you, Irina. Thanks for that introduction and thanks for organizing this webinar today. I'm very glad that we're having this conversation. As someone who's worked in infectious diseases for my entire career, I have found the last few years to be particularly staggering. I was looking, and as of today there are more than 616 million cases of COVID-19 that have been reported globally, upwards of 6.5 million diagnosed deaths that have been reported worldwide. At the same time, we are also seeing a global surge in cases of monkeypox, a disease that many hadn't heard of prior to this past year. And now we are over 66,000 cases that have been reported globally, more than 25,000 of those reported here in the United States alone. At the same time, successive outbreaks of Ebola have been occurring, and we have measles once again on the rise. And now vaccine-derived polio circulating in countries where the virus had been previously thought to be eliminated. So it's really a staggering list of infectious diseases that have been occurring and continue to occur. So clearly, we're at an important crossroads in terms of how we respond to these recurring hazards and infectious disease emergencies. But today we get to zoom out a little bit, and to examine factors that they may have all in common, and to try to understand what may be driving these—the recurrence of these events over and over again. So over the past few years we have seen the consequences of social, economic, and racial inequities play out center stage. These factors have underpinned not only our underlying vulnerabilities to infectious diseases, but also how effectively we respond to them. So that's what we're going to talk about today. And to help discuss these issues we are joined by two globally renowned experts who have a long history in working to address infectious disease threats and the disparities that accelerate them. Our first panelist is Dr. Demetre Daskalakis. Dr. Daskalakis is the deputy coordinator of the White House national monkeypox response. Prior to this role, he served as director of CDC's division of HIV prevention. And prior to that, oversaw infectious diseases for the New York City Department of Health and Mental Hygiene, which is one of the largest health departments in the nation and rivals the WHO in terms of staff and budgets. So Dr. Daskalakis is a leading national expert on many things, but also in particular health issues affecting the LGBTQIA+ communities. And he has worked clinically for much of his career to focus on providing care for these communities. We are also joined by Dr. Jeremy Youde, who is the dean of the College of Arts, Humanities, and Social Sciences at the University of Minnesota Duluth. Previously, Dr. Youde was an associate professor in the department of international relations at Australia National University in Canberra. Dr. Youde is an internationally recognized expert on global health politics. And he is a very prolific writer. He has written five books, and many chapters, and countless articles. I recently read a very compelling blog post by him on our own CFR's Think Global Health. So really excited to get both Dr. Youde and Dr. Daskalakis's perspectives on the issues in front of us. So I will get the conversation started. We have a lot of great attendees, and we'll have time for questions. But just to get the conversation going, let's see here. Maybe first, if I could turn to you, Dr. Demetre. For those who haven't been living in the monkeypox data as much as you have, perhaps you could just give us a quick summary of where we are and where you see us being headed. DASKALAKIS: Thank you. And thank you for having me. I'm really excited to join Jeremy and to be a part of this discussion. So living in the data is, in fact, what I do. So I'll tell you, so monkeypox—I'll give a little key bit of background just for everyone to be level-set—is an orthopoxvirus, that is a virus that causes disease, transmitted usually from animals to humans. Usually, traditionally, not a lot of human-to-human transmission. This current outbreak in 2020, global in scale, with 66,500 cases reported internationally, actually demonstrates pretty good human-to-human transmission, often in the setting of close contact, often associated with sexual activity, and the majority of cases being among men who have sex with men—the vast majority, over 96 percent. In the U.S., at this moment, we have 25,300 cases. I can tell you right up to the moment. And so we continue to see increases in cases in the United States, but we're seeing a deceleration in the rate of increase. So cases are stilling being logged. We used to see kind of around four hundred cases per day. We're now more on the order of two hundred or below and continue to see that trend going in a good direction with more data imminently coming to the website of CDC later on today. Again, just briefly, the demographic, majority male, mainly men who have sex with men—the gay, bisexual, other men who have sex with men. Looking at the demographics, at the beginning of the outbreak in May, the majority of cases were among white men. And now we're seeing about 68 percent of those cases are happening in Latino or Black men. From the perspective of that measure as well we've seen a significant increase in vaccinations. So we can talk—we're going to talk more about that, I'm sure. But really with lots of strategies to increase vaccine supply. We are now well over eight hundred thousand vaccines administered. There is an inequity there as well. The majority of vaccines are going to white men. And we're seeing Latino men and Black men in second and third place, respectively, in terms of vaccines administered. Jennifer, I hope that that's a good situation summary to start off with. NUZZO: Yeah, great summary. Thank you so much. That helped kind of bring everybody to the same—somewhat same level. Just a quick follow-up question for you. There have been a lot of headlines about the important progress we've made, and the fact that the global monkey—or, sorry—the monkeypox cases seem to be coming down in terms of numbers. Question: Are you seeing similar trends for all demographics? Or are you concerned that perhaps the large numbers are hiding increased transmission in other groups? DASKALAKIS: I had to fix the mute. There we go. So I think what we've seen is that the declines are looking to be even across population. So that's good news. Again, the vaccine equity is our main issue right now in terms of where we're—where that's stubborn right now, and really thinking about strategies to improve that. We had a lot of news today, which I'm sure we'll be able to talk about some of the strategies that we have to address that. But so I think there's no clear sign that the deceleration is different in different populations. Geographically, however, it is different. And so that's, I think, one place where—the jurisdictions that have had the greatest and longest experience with this outbreak, so the most cases, are also the jurisdictions that have access to the most vaccines. So whether it's because of behavior change that we're seeing, which is definitely something that we, I imagine, could talk about here as well, or natural infections plus vaccine-induced immunity, I think the places that have had more experience are showing deceleration faster. So New York, California, Texas, and Georgia are looking down, while some of the places where the outbreak is newer and they've also had less access and time for vaccines, those places are showing an increase. We're going to get an update of this, this week. So this is based on data that's about a month old. So soon we're going to have a new view into how this deceleration or acceleration looks like, jurisdiction by jurisdiction. NUZZO: Great. Thank you. Maybe turn to you, Dr. Youde. You've been an important voice about the global dimensions of the monkeypox crisis. And I'm just curious where you think we are globally. And I referenced in introducing you that piece that you wrote on Think Global Health that I thought was—made a quite compelling argument about the role of WHO and where you see the response needing to go. Do you want to maybe elaborate on those points for people who haven't had a chance to read your article? YOUDE: Sure. Thank you for the question, and thanks for organizing this. I'm honored to be part of this event. And, picking up on some of what you were talking about and what Demetre was just talking about as well, we do see these inequities that exist, especially when we're looking worldwide. The World Health Organization did declare monkeypox a public health emergency of international concern. And while it doesn't necessarily come with automatic funding or programmatic resources, it does raise the profile. It does put this on the global health agenda and say: This is something we need to be paying attention to. In the piece I described it as the WHO's bat signal. We're sending out the message: This is something that we need to pay attention to. But one of the things I think is frustrating about the WHO response, and just sort of the global community's response to monkeypox in general, is that monkeypox isn't a new disease. This is a disease that we've known about in human cases since 1970. Laurie Garrett in her book, The Coming Plague, which came out in '94—which is one of the books I think a lot of us who are probably about a similar age read in our early, formative days as we were coming into global health and global health politics—she talks about it in that book. And if you look at the data that we have, we've been seeing increases in monkeypox cases in humans in countries where monkeypox was endemic for about the last decade or so. And so—but what really caught the international community's attention was then when it came to the Global North, when it came to the industrialized countries. And that helps to reinforce some of these questions about what is the nature of our real concern about global health? Is it about health in this very broad mandate, like the World Health Organization has as part of its constitutional mandate, to be this international coordinating body? Or is the sense that we, in the Global North, want to keep the diseases from the Global South coming to affect us? And there are similar sorts of issues when we're looking at vaccine equity and vaccine access, when we're looking globally. And, there have certainly been some problems here in the United States, getting access to the vaccine. But, I was able to get vaccinated against monkeypox. Yeah, I had to drive two and a half hours to Minneapolis to do it, but I was able to do it. And I was able to arrange it. People in countries where monkeypox is endemic have little to no access to these vaccines. And it raises some of the questions then, again, about how the international system and the global health governance systems that we have in place—how they can address some of these equity challenges? Because in many ways, outbreaks like monkeypox, they glom onto the societal and social cleavages that exist, and help to reinforce and exacerbate them, but also provide this opportunity for us to really put some of our ideals and our promises around social justice, around a cosmopolitan view of understanding that we are all healthier if we are all healthier. And really put those into practice, if we have the political and economic will to do so. And that's where—that's one of the areas where I get a bit concerned right now. I know we're all exhausted talking about COVID-19 and about monkeypox, and all of these sorts of outbreaks. Jennifer, I know you've been doing a lot of this. Demetre, obviously, you've been on the frontlines. I've been doing some of this work as well. But when we lose that attention, sometimes we lose then that motive—that momentum in the political system to try to address some of these challenges and these shortfalls that we have identified. So, I can be a critic of the World Health Organization, but I also recognize that the World Health Organization is a creature of its member states. And so, it's really incumbent upon the member states to really put some action behind their words. And to say: If we want to have a more effective response, we need to build systems that are going to be able to respond better than this. NUZZO: Thank you for that. It's a good segue to what I wanted to talk about next, which is the title of this webinar being about social justice. And those who've worked in public health, the notion that social justice has a role to play in reducing our vulnerability to infectious disease is quite clear. But I'm aware, particularly over watching—(laughs)—the national political debate over the last several years that those outside of public health may not recognize the connection between our vulnerability to infectious diseases and social justice. And they may be dismissive of the idea that public health authorities should be engaged in the work of social justice. So this is actually a question for you both. And maybe reflect on monkeypox or your long experience of other infectious disease threats that you've worked to address. And what would you say to folks that just don't understand why public health should be concerned with social justice, and what role do you think it has to play going forward? And maybe we'll turn back to you after Demetre. DASKALAKIS: Do you want Jeremy to go or do you want me to go first? NUZZO: Go ahead. YOUDE: Go for it. Go for it. I'll let you start. DASKALAKIS: All right. So I'll put my very strong HIV hat on, because that's sort of where I come from. And I'll start that this is a forty-one—a forty-two, almost, year-old lesson that I think we've seen play out over and over again, which is that really the social determinants of health are actually what drive infection. So there are countermeasures that can work. There's vaccines. There's drugs. There's pre-exposure prophylactics, post-exposure prophylactics. It doesn't matter. The social determinants are really what ultimately ends up blocking us from being able to implement the full vision of what we know we can from the perspective of medical technology and public health. And so I think that at the end of the day that implementation piece is so critical. So much technology can exist, so many interventions can be designed, but they sit on the shelf unless there's both the political and social will to move them forward. And so I think I should put that HIV hat there for a second, because in environments where there is less political and social will we tend to see HIV flourish. And in places where there is social and political will, we tend to see HIV not do so well from the perspective—or, in other words, we will do well because of less incidents and prevalence. So I think that sort of looking at that will is so critical. I'll give you a story from monkeypox which I think is really important, that is about the sort of CDC response. I got pulled in really early on, before the first case actually hit the United States. One of the very early conversations that we had with the response is that we need to expect that we're going to have inequities that are going to be a part of this. And I think that's based on lessons from COVID, and lessons from HIV, and lessons from so many other infections. I think we really worked to make equity the cornerstone of the response. But even when you do that, it is an all-of-society thing that needs to happen, and not just something that is mediated simply by a public health department or a public health agency. Over. YOUDE: And if I can take that public health hat and HIV hat that you had on, and I'll wear it myself. I got into this line of work through working on HIV/AIDS issues in Zimbabwe and South Africa, and seeing how those sorts of societal cleavages played a role, but then also how infectious disease outbreaks, and the spread of HIV was glomming into these other issues around democratization, around building societies that were going to be equitable, that were going to be able to fulfill the promises that governments had made to their populations. And seeing how a disease like this was thwarting that progress. So it's something that is not just unique to the United States. It's something that we see globally. From a very instrumental perspective we can say, look, public health is ultimately a weakest link public good. Everyone is still at risk, so long as risks still exist. So we need to reach out to those places which might have fewer resources, which might not have the same sorts of ability to implement these sorts of programs, because ultimately that's going to make us all healthier. And I think there's elements and an important role for those sorts of instrumental views of public health. But I also think about the recently passed Paul Farmer, and his notion of public health, especially his idea around the preferential option for the poor, which was kind of a double-edge sword. Because on the one hand he was saying, look, the people who are disenfranchised within societies, those are the people who are the most vulnerable to these infectious disease outbreaks. Those are the people who are at the greatest risk. But also, we need to think about our programs, we need to think about our interventions putting those people first, thinking about equity. Putting that not as an afterthought or something that we think about five, six, seven steps down the road, but it needs to be central, and it needs to be core. Because, again, if we're not taking equity seriously and we're not really putting this into everything that we're doing, then we're just reinforcing these sorts of divisions and, again, providing these opportunities and these outlets where diseases can thrive. And so, to just cosign what Demetre was saying we can have all the technologies we want. And I have all my criticisms about the way that the access to pharmaceuticals and drug interventions exist on a global level, and questions about compulsory licensing and all these sorts of things. Those are all important, but those are secondary in a lot of respects if we don't have the underlying core infrastructure in place. And that core infrastructure, even if it's not touching us in a direct way, does have an effect on our ability to stay healthy. DASKALAKIS: Could I—this is a fun one. Could I keep going a little bit longer on this? NUZZO: Please do, yeah. DASKALAKIS: This is a great, stimulative conversation on this. And along with what ends up being both the foundation of the issue as well as the deeper foundation, the way that all of these social issues interact with stigma, like I think we've seen in fast-forward with monkeypox. Like all the things that we saw with HIV and other infections and COVID—today, for instance—this is a really good example. So, we're giving the vaccines and right now they're going on people's forearms. Which means that literally some people will have a mark on their forearm. So talking about stigma—literally stigma. And so, we changed it so that individuals can elect to get the vaccine on their shoulder or on their back. So we have people who want vaccines but are saying, I don't want to be marked by this. I don't want to have the sort of—someone know that I am someone who's potentially identifying myself as part of a group at risk. And so it interacts exactly with the social determinants. Whether it's poverty, transportation, racism, all of it interacts in a way where these sort of more brass-tacks economic issues interact with these very profound stigma issues and create barriers where even if you do have great access—I'll give an example again. [The] Ryan White [program] is really great access for people for HIV medication, but we still don't have everybody in the country—(inaudible)—right? So why is that? It's partially access, but it's also that the systems are built to sort of maintain structures of stigma and structures of inequity that are really hard to overcome, even with things that provide access. NUZZO: So I was actually going to ask you about stigma. So thank you for segueing to it. And I seems to me that—and I don't have the HIV hat to wear, like you both do. But studying events that we typically think about in the field of health security—which is a field that sort of struggles to incorporate the forty-plus year lessons that HIV has learned—is that it is clear that stigma is an issue in nearly every single event. Any time we have particularly a new infectious disease, or something that's unusual, society seems to look for some group to blame. But what it seems, though, is that while there's an increasing recognition of the importance of stigma, it doesn't seem like we have great strategies for addressing it. And I guess I'm wondering, do you agree? And also, what practically can and should we be doing to address stigma? I really saw us struggle with this. I mean, we had a recognition of it as being important in monkeypox, but I feel that the absence of clear ways to deal with it really led us to struggle to talk about monkeypox, and who was at risk, and how people could protect themselves. So what should we be doing going forward not just for monkeypox but future threats, so that we don't get hobbled by—first of all, that we can minimize or tackle stigma, but also don't get hobbled by it? Whoever wants to chime in. (Laughs.) DASKALAKIS: So this is back to the HIV hat. This is the tightrope that we walk every day in HIV. And I think that the lesson actually—well, one of the first lessons that's important, sort of sitting on the government side of the world, is that government needs to lead, and governmental public health needs to lead, so that its messaging does not propagate stigma. That's very important. Because whether people like governmental public health or not, or have complaints about it, ultimately people do look to governmental public health—like CDC, local health departments—to really fine-tune their own messaging, and then translate that messaging not just to another language but translate it so the populations that people work with actually understand. And so I think monkeypox was actually a kind of exciting example, where from the very beginning of the response it was a how can we take an anti-stigma stance in how we messaged it? And so the balance really then depended on the data. And so that's what was really important. So it was starting with imperfect data, and as the data became more and more clear, making sure that the messaging evolved in a way that addressed what you were actually seeing epidemiologically without necessarily—without creating a scenario where you're pinning infection, a virus, on a population. Let me give you an example since, Jennifer, you say your HIV hat isn't as strong as ours. So in the '80s, when HIV started, before it was HIV it was gay-related immunodeficiency. So that lesson was the lesson that was so important in the work that we did with monkeypox, to start off by saying: This is a virus that can affect anyone. But we're seeing this virus more in this population. As opposed to saying: This is this population's virus. And so it's leading by that example. And it's one of those things that we can raise up and say: We have learned the lesson from this forty-two years ago, and we're not doing it this way again. And so with that said, I think that there's a lot of strategies that can address stigma. And a lot of that has to do with communications, using trusted messengers. So, that has been a really important part of this as well because, again, working in public health I would love if everybody listened to public health data. So providing good communications to individuals who are trusted messengers is really important. And also, part of the propagating stigma is also being clear about what data is, things that we fully know and things that we're still learning. Because that really allows that risk communication so that you don't over-select or too rapidly move a response into what population, as opposed to being broad. So as you learn more data—so, for us, our guidance started off in one place about safer sex and safer gathering. As we were seeing that this was not moving throughout the different populations, it got stronger and stronger. And we really started the conversation by saying that this is guidance that's going to change as we learn more. I think that we do have stigma mitigation strategies. But stigma's a stubborn thing. I'll give it over to Jeremy. YOUDE: Yeah, I would agree with everything that you said. And especially being—having that level of humility. We are still learning about this. Things are going to change. Things are going to evolve but building those sorts of trusting relationships. The other things that I would emphasize, and I think these complement what you were saying quite well, is empowering communities to speak to each other. I think one of the things that we've seen here in the U.S. around access to the monkeypox vaccine, and the relatively high rates of vaccination that we've seen, has been people talking to other people. Men who have sex with men talking to other men who have sex with men, and this becoming part of the conversation. Even if it is something at the level of, where were you able to get access to it? When supplies are limited. Just building that sort of awareness within a community can be incredibly important. I think it's also important to make sure that we do have targeted messages. Not blaming messages, but understand that the message that just says, everyone is at risk for HIV or everyone is at risk for monkeypox, ends up falling flat and doesn't really strike anyone. And so having that sort of targeted outreach plays an important role. But going back to this point about empowering the affected communities, one of the most powerful things that I think that I've seen in the work that I've done is looking at the Treatment Action Campaign in South Africa, and the work that they did, especially in the late '90s and early 2000s, with the T-shirts that just in huge, bold letters across the chest said: HIV positive. And just having people going out there, wearing those T-shirts. The image of Nelson Mandela wearing one of those Treatment Action Campaign T-shirts is just incredibly important because, again, it's helping to remove some of that stigma. It's getting people who are trusted, who are respected, coming into the conversation. OK, if he's involved in this, if he's saying this is an important issue, maybe this is something that I need to be paying attention to. But also just trying to make that sort of availability, so that people are willing to share their experiences, or talk about what's going on, or what worked, or what didn't work for them. Again, these all play really important roles. It's never going to be perfect. It's something that we do need to keep at the forefront when these sorts of outbreaks happen. And you see some of this in some of the broader conversation around even what we call diseases, the names that we use. The fact that there is a very strong move away from geographically located names for diseases, because we don't want to stigmatize those particular communities or people who happen to be coming from those areas. Even something like that can play a really important role in helping people to think, this is something that I need to take seriously if I'm in the United States, I need to take this seriously. Even though we're talking about something like monkeypox, which isn't a geographic designator but there aren't a lot of monkeys roaming around in Minnesota. But it's something that they should be taking seriously, because of these effects and these sorts of community-based responses that help to try to destigmatize things, encourage people to get access to vaccines, or treatments, or other sorts of options that are available to them, and start to have those conversations to empower communities. NUZZO: That's great. I'm going to turn over to questions. And maybe participants can start putting their hands up. But while that's happening and before I turn it over for that section of the conversation, one last question to you both. Which is, I am deeply worried that we respond to these events as these one-offs. We have an emergency, we get emergency funding, then perceptions of the emergency being over, the funding disappears, and it's gone. And we saw that happen with COVID, where the money went away and then states had to let go their pandemic hires. And guess what? They weren't there when monkeypox happened. So I guess the question is, how do we move away from sort of seeing these as just one-off emergencies, and moving towards a role where we create a durable sort of permanent system that's in place to snap into action anytime there's an event, which is happening—which we're seeing—these events are happening with an increasing frequency? YOUDE: I'll jump in first, Jennifer. It's like you're reading the paper that I've been working on throughout the event today. And that's part of my concern about WHO designating this to be a public health emergency of international concern, when we're talking about monkeypox or COVID-19 for that matter, is the emergency framework. Public health, when it's doing its job, we don't know about it. It's something that—where we're essentially trying to stop things before they reach that level of public consciousness, or stopping it really, really early in the process. And so the emergencies, they get the attention for global health but they don't necessarily get the long-lasting system. It becomes, like, OK, whew, we got through that. We can move onto the next thing, or we can just not pay attention to global health again until the next system comes up. But at a very fundamental level we have this organization. We have the World Health Organization, which has this constitutional mandate to act as this international coordinating body for health—cross-border health issues. And it has a smaller biennial budget than many large hospital systems here in the United States. So how is it going to be able to do that sort of work when it has so few resources? Plus, given the way that the WHO is funded, it only has control over about 20 percent of its budget. The rest of it is coming through these voluntary contributions, which are generally specified for specific purposes, which may or may not align with the purposes that the WHO itself would put in place. So I think that one of the things that happens there is it behooves us, it behooves the member states to actually—to put some diplomatic and political capital behind this, to actually move on this. I have no doubt that in a few years' time we will have some sort of after—some sort of response that will look at the response that WHO made to COVID-19. And it will bemoan the failures. And it will talk about all the things that need to change. And then it will gather dust on the bookshelf. And we will get similar sorts of things for monkeypox. And what we haven't had is a country or a group of countries, or some sort of person with high stature, really glom onto this and be like, yes. We need to do this. This is our potential roadmap for trying to address this in the future. I—nerding out in the global health politics world—I had this idea that someone like a Helen Clark, or an Angela Merkel, someone who knows international politics, who knows the systems, who has that sort of diplomatic experience, but also is concerned about issues around health, that could be the person who could help to inspire some of these actions, and could get the attention of world leaders in a way that civil society organizations often aren't able to do. Which is not to say anything bad about those organizations, just that there are structural problems getting the attention of world leaders, and having that sort of concentrated attention. So I think we—ultimately, we need a champion. We need a person, or a country, or a group of countries who are willing to really champion this, and go to the mat for trying to make these sorts of changes, so it isn't just emergency, after emergency, after emergency, but something that is going to be more long lasting, that is going to provide that sort of infrastructural support, and make sure that we aren't just lurching from here, there and everywhere, but actually can have some sort of coordinated response and something that is a bit more forward-thinking. But it's a challenge. NUZZO: Demetre, the bullets of your bio—(laughs)—are a list of the emergency, after emergency, after emergency. So I know you have first-hand perspectives of this. So any hope we can fix it? DASKALAKIS: Sure do. (Laughter.) So, my perspective may be very domestic, but I actually think it's not. I think when I start talking, I think it's going to seem as if there's also infrastructure that needs to be leveraged internationally that's similar. Which is, I always think about what actually worked. And so one of the things that I think we're seeing over and over again, whether it's COVID, or monkeypox, or other outbreaks, is leveraging systems that already exist, and really figuring out how to support those systems during peacetime as well as wartime, so that it stays warm for a response. And that's a very public health—it's a very sort of operational, public health example. So I'm talking HIV. I'm talking chronic infections. I'm thinking domestically, we have this excellent—I think the HIV Epidemic Initiative, it's not nationwide yet. It hasn't been resourced to do that. But, if it were, that is a really sort of important way to be able to create and maintain an infrastructure. So thinking about sort of chronic diseases like viral hepatitis, having an infrastructure that could potentially lead to curing more people with viral hepatitis creates a system that then could be used for care and other public health delivery of countermeasures. So thinking about things that—what can we do to sort of do our peacetime work, which is around chronic infections like virus hepatitis and HIV, and what can we—and STIs, which are out of control in the United States, mainly because they're under-resourced—but what can we do sort of to maintain sort of those systems, so that when we flip the switch from peacetime to wartime that we can pivot those resources to do the work? I'll give an example from the research universe—monkeypox, as an example. Right now, there are studies that are going on for monkeypox vaccines and for monkeypox therapeutics. And they're built on the networks of HIV investigators. So, HIV Vaccine Trials Network and AIDS Clinical Trials Group are currently the people that are doing those studies. And sort of research funding potentially being a bit more flexible, that pivot is possible. But what if we had similar models sort of in the operational world of public health, where you have sexual health clinics or STD clinics that are doing HIV/STD work during peacetime, but can flip into monkeypox vaccines and testing in wartime? And so it's investing in a chronic infrastructure to be able to make it translatable into an emergency response, in a nimble way, I think is really important. And of course, I back up Jeremy. That idea of political will and leadership is really important in making sure that this sort of moves forward in a way that works. But, I mean, I say this domestically, but then one can conjure PEPFAR in terms of an infrastructure that works. So that—they have been leveraged. And so what if we worked harder to make sure that they were resourced adequately during the peacetime, so that during wartime they flip and are flipped more effective? And by the way, that HIV positive T-shirt has influenced my career, Jeremy, in terms of seeing people who were willing to put on a shirt that really works against stigma. My favorite being Annie Lennox, who I met with that T-shirt on, and I was very excited, as a fan. But definitely an important thing to reclaim that stigma. Jennifer, thank you. YOUDE: And if I can build on what Demetre was saying, think about the Ebola outbreak in West Africa in 2014, and the cases that popped up in Nigeria. That led to all sorts of concern. Now you've got someone who has Ebola in Lagos, a city of twenty million people, and just not a city that necessarily has the sort of infrastructure in place that you're going to think, oh, we're going to be able to contain this. But they were able to repurpose existing programs. They were able to use measles control programs and other sorts of programs. And, using the word that we have all become way too familiar with over these past two and a half years, they pivoted, turned that into doing the surveillance and doing the contact tracing for Ebola, and were able to stop the spread, and being able to prevent that from spreading rampantly throughout one of the largest cities in the world. And I think that's the sort of thing, you know? If we have these sorts of structures in place, we can adapt them. Even if they are for one purpose, they can be adapted for other purposes. And so it's not that we need to recreat the wheel each time, it's that we need to figure—we need to make sure that we've got enough wheels out there, essentially. DASKALAKIS: And that goes for surveillance. Maintaining good surveillance systems for chronic things means that when an acute thing comes up, that good surveillance already exists there. So not only for an operation, but also for being able to understand what's happening with the threat. I like to call it keeping the system warm, if you think of sort of the stuff that's happening. So when you have to heat it up, you're not starting from—it's not a TV dinner you're taking out from frozen. It's thawed already. You can move quickly. NUZZO: It's really hard to build capacities in the midst of an emergency. So thank you for those thoughts. I am going to give others a turn to ask questions and turn it over to the question-and-answer session now. OPERATOR: Thank you. (Gives queuing instructions.) Our first question comes from Mark P. Lagon from Friends of the Global Fight against AIDS, Tuberculosis, and Malaria. LAGON: Hi, there. Thank you for this really thought-provoking forum. I come from a perspective working in the health field, but also background in human rights. I was an adjunct senior fellow at CFR, and president of Freedom House. I wonder, to take some of the points that Jennifer Nuzzo has been making and posing to you, to move to pandemic preparedness. If you have—we've seen that AIDS confronts one with very clear human rights and equity issues, particularly for stigmatized populations. You have a kind of a reprise with monkeypox. There was a lot of discussion about in terms of the impact of COVID and equity on vaccines. As the international community has moved to form a fund housed at the World Bank, how do you embed preparation for pandemics to have a human rights or social justice perspective? Activists really had to push hard to get two voting seats for civil society on the governing body of that fund. Thank you. NUZZO: Anyone want to take that on? (Laughs.) YOUDE: Sure. I'll offer a few thoughts. I think this is something—again, this is something to be thinking about at this early stage. As these sorts of systems are being designed, as they're being set up, keeping these sorts of elements important and at play. But I also think it's important to make sure that there are multiple channels for this communication to happen. That there's one thing to talk about formal board seats, and those are obviously important to have people at the table for these pandemic financing facilities through the World Bank and other sorts of organizations. But also make sure there are other opportunities, because new organizations may pop up. They may change. Depending on the particular circumstance or the particular outbreak that we're talking about, there may be other groups that are being mobilized and being affected by this. And so, there needs to be a certain level of nimbleness that needs to go into this. I think it's also something that puts a lot of—we need to put pressure on our leaders to really put their promises into action, to make sure that this isn't just something that we have as a tick box exercise. Oh, yes, equity is important, we need to address this. But actually, that there is this ongoing pressure and this sort of check of what are we actually doing here? Are we reaching out to these communities that are being affected? How can we better do this? And so I—again, there's an interesting moment right now that we can hopefully seize to make sure that this is something that really does get instantiated within these systems. And I hope we don't let that moment pass. I hope we don't decide to just we'll go back to existing systems. Because that's the other thing that goes along with this. It does challenge the status quo. It does challenge the sorts of standard operating procedures that we have in these organizations. And that can be challenging. That can be a difficult sort of conversation to have. And we have to be willing within our international organizations and other sorts of responses, we have to be willing to have those conversations. We have to be willing to challenge ourselves and to criticize ourselves, and to then make changes that are going to be effective. LAGON: Thank you. DASKALAKIS: I don't have almost anything to add to what Jeremy said. I think there really—again, the political will is important. And just we've all experienced that U-shaped curve of concern, right, where when things are very exciting everyone is very worried and engaged, and then when it fades away, resources fade away. And what that means is the infectious disease comes back. And so it's really—whether it's the same or a different infectious disease, sort of keeping that momentum and having it really come both from the political piece, from organization, but also from the side of advocates and activists is really critical to keep the—to keep the energy moving and the momentum moving. We have to make sure that we come to a better place. Every event, you learn more. And so I think that even if we take a quantum leap in what preparedness looks like, whatever the next event will challenge that level of preparedness and will require us to then—to really develop systems that are—that are updated based on the experience. So I think moving the needle anywhere, but moving it in a coordinated way because of that will and that strategy is the most we could hope for and the most we should expect. Or the least that we should expect, the minimum, of being able to move to a place where we have something that is better than how we found it, and potentially more resilient in terms of a—monkeypox is minor compared to COVID, after COVID. NUZZO: Yeah. I mean, I think the more we have these events the more we learn, though it does feel to me a little bit like the more we have these events, the more we learn the same things over and over again. (Laughs.) And particularly when we're talking about these inequities. And Jeremy pointed out about the stark inequities in terms of who's able to access vaccines in the globe. And that was clearly something that we saw throughout much of COVID-19, still see it today. We saw it during the 2009 H1N1 pandemic, in terms of who had vaccines and who didn't. So I guess the question—and I recognize that we have just about ten minutes left, and the CFR rule is we always end on time. So I'm going to—(laughs)—I'm going to be aggressive about that. But just on that point what do we need, I think, to put into place? We talked about how there's a pandemic fund now, which is important. But aside from money, and maybe it's just money, what else do we need to kind of create structures to address these inequities globally? Given, Jeremy, you also made the important point about—I've been struck by how hard it's been to contain monkeypox here in the U.S. But let's say we're successful, we're still going to have challenges as the virus continues to circulate. So we need to make progress globally. And we need to have systems in place such that every time these emergencies happen, we don't keep learning these same lessons over. So maybe just two or three minute each, your takeaways on what you would do to fix these problems if you were deemed in charge of the world. YOUDE: A little new world, just like that. Money is obviously important. The amount of money that we spend on development assistance for health has gone up dramatically since the early 1990s, but it still pales in comparison to the level of need. So there is just a basic resource need. The second is that we need to make sure that systems that we are building are not for specific diseases, but are things that can be flexible, things that can be adapted. We don't want to just say: Now we're going to set up all these monkeypox surveillance systems, when that may or may not be what is going to be the next big outbreak. So we need to have things that are going to be able to be flexible like that. Third, we need to have—we need to have a better sense of just our—I guess our international community's willingness to engage with global health. We have the international health regulations. So we do have an international treaty that's supposed to govern how states respond to infectious diseases and their outbreaks. But the willingness of states to abide by that varies quite dramatically. And so we need to have a big of a come-to-Jesus moment about what are we actually willing to do, when push comes to shove? And then last thing I'll say is that I do think we need to have a conversation around access to pharmaceuticals and vaccines and other sorts of medical interventions like that. Because we know that there are inequities, and we know that oftentimes the communities that have the least access are the communities that have the highest rates of incidence or are in the most need of these sorts of things. And our structures are not really well designed for getting people access. Even though there are things like COVAX, even though there are things like PEPFAR, and all these other sorts of programs, which have done tremendous work, they are still falling short. And so we need to—we need to have a better sense of what—how do we actually put these sorts of things into practice? How do we actually make sure that these scientific breakthroughs that are so invaluable are reaching all the people that need to be reached? DASKALAKIS: Ditto, I'll start off. So that makes my job a little bit easier, because I think what Jeremy said is really important. I'll say again, I think in my hierarchy the first and most important thing is consistent political will, because I think that that then drives a lot of what happens beyond that. So I think that that really jives really well with what Jeremy said, in terms of that sort of commitment. Money is very important, I think, but it is not the only thing that drives us into preparedness. So I think that having that commitment. I also would like to think about that investing the money in things that keep the system warm. So I'll go back to that sort of statement, or like thinking about investing in the diseases that we still haven't finished. We still are working—we've got HIV, we have hepatitis, malaria internationally that we're worried about. There are a lot of areas that we could invest to create systems that are infrastructures that keep it warm for operation for pandemic. I cannot say it loud enough that what Jeremy said about flexibility is right. You can't really build the infrastructure on chronic disease if it's not flexible to move to another acute event. So it needs to be something that is both creates and maintains the infrastructure, but also has the ability—everyone's favorite word today—to pivot into the emergency response zone. So very important. I think also workforce and data. I think that it is important to remember that we talk about giving patients trauma-informed care, but we need to give our workforce trauma-informed care. COVID has been hard. Monkeypox has been hard. Our next challenge will be hard. And sort of how can we support the workforce and then also continue to mentor it to be able to do the work? Data also is so important. A commitment to share data, and to have data that is accessible for decisions, even if it is imperfect. And then finally, the realization—and it goes back full circle, Jennifer, to your first question—about our—or, maybe second question—about the social determinants. There's only so much that public health can do. There is an all-of-society need to address the core drivers of so many of the inequities. We can't solve everything through public health. We can get closer to health equity, but ultimately the goal is that as you access is really to go into social justice, which is not just public health but really an all-of-society endeavor to try to improve the environment so that we don't have fertile ground for these pandemics to blossom and grow. NUZZO: Thank you. There's a question that just popped up in the Q&A box. And we just have a few minutes. It's about the privilege of good information and how we address misinformation and disinformation, which likely leads to fragmentation. I will just chime in, having done a lot of communication over the past two years, I think that this is not a problem that public health can solve. I actually think the drivers of this are much, much larger. And I think we need an all-of-government approach to this that includes the potential regulation of the platforms. But I'm curious if you all have any quick comments to add to that. DASKALAKIS: I mean, I just agree with you. (Laughs.) It's definitely much bigger. There are things we can do, like monitor social media and make sure that our messaging is one way. But ultimately this is an issue that's bigger, that requires not just the public health lens to address. YOUDE: And, at the same time, we also can recognize that those trusted outlets, those can be really important tools. So, churches in sub-Saharan Africa played a really crucial role in many parts of helping to decrease HIV stigma, helping to get access and information out there about testing, about protection, about these sorts of things. I mean, that can also be the flipside, though. If you got these trusted sources that are peddling this misinformation, then it becomes this much bigger issue that goes beyond what public health can do. So I guess it's—part of it is just figuring out where those allies exist, be they in government or outside of the government, and what sorts of connections they might have with populations. DASKALAKIS: And to your earlier point about building those connections prior to events, so those relationships exist and you're not trying to forge them in the midst of a crisis. NUZZO: Well, really, thank you both. I wish I could appoint you both in charge of the world, because if I was asked who should be in charge of the world you would both be on the top of my list. But I am very glad that you continue to do the work that you do and contribute in important ways. And have both been really guiding voices as we continue to experience these events. So thank you very much for that, and really thank you to our participants for attending and the thoughtful questions. FASKIANOS: I second that. Thank you all. And we appreciate your taking the time to do this. I hope you will all follow their work. For Dr. Daskalakis, you can follow him at @dr_demetre. Dr. Youde is at @jeremyyoude. And Dr. Nuzzo is at @jennifernuzzo. Pretty easy. So we also encourage you to follow CFR's Religion and Foreign Policy Program on Twitter at @CFR_religion and write to us at outreach@CFR.org with any suggestions or questions. We want to help support the work that you all are doing. And we hope you will join us for our next Religion and Foreign Policy Webinar on the Politics of Religion and Gender in West Africa, on Tuesday October 11 at 12:00 p.m. Eastern time. So thank you all again for being with us, and thank you for your public service. We appreciate it.

In this episode, Sujani sits down with Stephanie Moxley, the founder of Moxley Public Health Consulting. They discuss Stephanie's journey into building her own public health consulting company and talk about what goes into becoming a successful entrepreneur in the public health field.You'll LearnStephanie's path to public health and what drew her to the MPHHow parenthood has changed Stephanie's career path and advice for other new parents that are managing their own businessesWhat Moxley Public Health is and why Stephanie wanted to start her own consulting company What challenges Stephanie faced and early successes she achieved through her companyWhat kinds of projects Moxley Public Health takes on and how the company has evolved over the yearsFuture plans and new initiatives Moxley Public Health has in storeAdvice from Stephanie for fellow entrepreneurs including what character traits or skills may help someone become a successful entrepreneur How networking is essential in working as a consultant in public health and tips on how to cultivate this skillToday's GuestStephanie Moxley is the owner and founder of Moxley Public Health (MPH) Consulting. Stephanie first began her career in public health 20 years ago as a health educator and program coordinator focused on HIV/STD prevention at the GO GIRL! Program at Bronx AIDS Services in Bronx, New York. After discovering her passion for the field of community public health, she moved to Boston and continued her education and training at Boston University School of Public Health. During graduate school, Stephanie was chosen for the HIV Social and Behavioral Sciences fellowship, worked full-time as a research assistant in a youth alcohol and marijuana study conducting motivational interviewing, was the president of PHAM (Public Health Alliance for Minorities), and completed her internship conducting health education at a rural community in Jamaica. Following graduate school, Stephanie worked on several projects from the local level all the way up to CDC federally funded projects. Stephanie has committed her career to focus on health promotion, addressing health disparities and inequities, and working to improve the health of both rural and urban communities. Stephanie seeks to understand a problem and finds a solution that is driven by data and evidence-based practices. ResourcesLearn more about Moxley Public Health ConsultingConnect with Stephanie on LinkedInOther PH SPOT resources:Share ideas for the podcast: Fill out this formNever heard of a podcast before? Read this guide we put together to help you get set up.Be notified when new episodes come out, and receive hand-picked public health opportunities every week by joining the PH SPOT community.Contribute to the public health career blog: www.phspot.ca/contributeUpcoming course on infographics: phspot.ca/infographicsLearn more about PH Spot's 6-week training programSupport the show

Adult content.GUEST BIO and LINKSPhil Miner creates spaces where people explore their desires free from judgment and stigma. He's the man behind Pheromone NYC, a party for armpit enthusiasts. He is also the man behind Natural Pursuits, a magazine for queer nudists. Prior to founding PM Pursuits (the umbrella organization), Miner worked in digital HIV/STD education in a healthcare setting where he won a society of illustrators Silver Medal for Art Direction for a PrEP campaign. NaturalPursuitsMagazine.comTwitter.com/PheromoneNYCInstagram.com/PheromonePartyNYCTwitter.com/PursuitsNaturalROBERT BLACK LINKSRefer friends to SexualHeroes.comJoin the Facebook group at Facebook.com/groups/SHHeroesandFansFollow Robert on Twitter at Twitter.com/RobertBlackXXXFollow Robert on Facebook: Facebook.com/RobertBlackonFacebookSubscribe to Robert Black News Robert's home page: RobertBlackXXX.comEndorphin High - School of BDSM: Endorphin High.orgSUPPORTAmazon Wish ListBuy Robert a Coffee: BuyMeaCoffee.com/SexualHeroesBecome a Patron: Patreon.com/SexualHeroesSupport the show

A motivating and inspiring discussion with Drs. Albritton and Anglin around how they are leveraging the Power of Big and Small Data to bring about Big impact with a Photovoice project. From collecting and analyzing data on how adolescents and their parents in Black and Latino families in the Bronx are coping during the pandemic to how anti-Black racism shows up in the community for young Black individuals with early psychosis, the Drs have uncovered some unexpected and surprising outcomes! Attention needed...·         Stronger connection between research and policy·         Change in Systems and Priorities Tashuna Albritton, PhD, MSWtalbritton@med.cuny.eduLinkedIn - https://www.linkedin.com/in/tashuna-albritton-phd-msw-53644940/Tashuna Albritton, PhD is an Assistant Medical Professor at the City University of New York (CUNY) School of Medicine in the Department of Community Health and Social Medicine. Dr. Albritton has extensive training in community-based HIV/STD behavioral intervention research, particularly with underrepresented minority adolescent and young adult populations, in both urban and rural communities. She uses a mixed-methods approach and participatory methods to examine individual risk for HIV/STDs, interpersonal relationships, and community factors that impact disparities in sexual and reproductive health among young and disadvantaged populations. Dr. Albritton is interested in using online platforms to promote biomedical HIV prevention methods in high-risk populations. Deidre M. Anglin, PhD , MSdanglin@ccny.cuny.eduTwitter – @DeidreAnglinDeidre M. Anglin, PhD is an Associate Professor of Psychology in the Doctoral Clinical Psychology Program at The City College of the City University of New York (CUNY) with postdoctoral research training in psychiatric epidemiology at Columbia University's Mailman School of Public Health. Dr. Anglin leads several projects and mentors students in her Clinical and Social Epidemiology (CASE) Lab designed to identify social determinants of psychosis risk in racial and ethnic minoritized populations.  She has published several papers focused on race, racism, psychosis and the stigma of mental health service utilization in Black and Asian populations. She is currently the lead investigator of 3 federally-funded studies, one of which examines anti-Blackracism and neighborhood factors among Black young people with a first episode of psychosis. She is one of the First 100 doctoral scholars in the Leadership Alliance and a member of NIH's National Research Mentoring Network (NRMN).Subscribe to our podcast, and leave a reviewConnect with us on Instagram, FaceBook, Twitter , and LinkedInhttps://eima-inc.com/lets-talk-small-data@letstalksmalldatapodMusic credit: Yung Kartz

Best of Insight 2022. Book “Taking Down Backpage: Fighting the World's Largest Sex Trafficker.” Missing indigenous women crisis in Northern California's Lost Coast. Sacramento County is a hot spot for new HIV infections in the United States. Today's Guests Prosecutor Maggy Krell discusses her new book, “Taking Down Backpage: Fighting the World's Largest Sex Trafficker,” which explains the misunderstandings of human trafficking and how social media and the internet make it more difficult to track and prosecute. Dr. Blythe George, Assistant Professor of Sociology at UC Merced, member of the Yurok Tribe and research partner for the “I will see you again in a good way” project on Missing and Murdered Indigenous Women, Girls and Two-Spirit peoples, discusses a missing women crisis in Northern California's Lost Coast. Jacob Bradley-Rowe, Executive Director of the non-profit Sunburst Projects, discusses new grant funding for HIV and STD testing in Sacramento County, which is one of 40 hot spots for new HIV infections in the United States.

Ending statewide indoor mask requirements at schools. Tahoe Basin residents “quality of life” community survey. New grant for HIV and STD testing in Sacramento County, which is one of 40 hot spots for new HIV infections in the United States. Today's Guests Dr. Hakeem Adeniyi, Medical Director of the Sacramento Native American Health Center, discusses ending statewide indoor masking requirements at schools.  Tahoe Prosperity Center CEO Heidi Hill Drum and Envision Tahoe Co-Chairman Chris McNamara share with us the key findings of a community survey from residents living and working in the Tahoe Basin.  Jacob Bradley-Rowe, Executive Director of the non-profit Sunburst Projects, discusses new grant funding for HIV and STD testing in Sacramento County, which is one of 40 hot spots for new HIV infections in the United States.

Today I talk with anthropologist Thurka Sangaramoorthy. Thurka Sangaramoorthy is a cultural and medical anthropologist and public health researcher with 22 years of experience conducting community-engaged ethnographic research, including rapid assessments, among vulnerable populations in the United States, Africa, and Latin America/Caribbean. Her work is broadly concerned with power and subjectivity in global economies of care. She has worked at this intersection on diverse topics, including global health and migration, HIV/STD, and environmental health disparities. She is the author of two books: Rapid Ethnographic Assessments: A Practical Approach and Toolkit for Collaborative Community Research (Routledge, 2020) and Treating AIDS: Politics of Difference, Paradox of Prevention (Rutgers, 2014), and has two books in press: She's Positive: The Extraordinary Lives of Black Women Living with HIV (Aevo, 2022) and Immigration and the Landscape of Care in Rural America (University of North Carolina Press, 2023). Dr. Sangaramoorthy is Co-Chair of the American Anthropological Association's Members Programmatic Advisory and Advocacy Committee and a Board member of the Society for Medical Anthropology; she serves as Associate Editor of Public Health Reports, Editorial Board Member of American Anthropologist, and the inaugural Social, Behavioral, and Qualitative Research Section Editor for PLOS Global Public Health. She is currently Associate Professor of Anthropology at the University of Maryland. 

Health Innovation Voices: Deeper Conversations (HIV-DC) Podcast Episode 1: In this deeper conversation, we discuss the barriers and stigma faced by Black women around HIV. Dr. Tamara Henry, Associate Professor and Practicum director at the Milken Institute School of Public Health at George Washington University, joined us to examine the factors that contribute to adolescent and adult Black women being overrepresented among people living with HIV in the United States, and what can be done to change that. Continuing Education Credits are available for this podcast. For more information visit: EffiBarryInstitute.org/podcast. Resources: Check out the CDC HIV testing website for more information on HIV & STD testing centers near you! Black women in the U.S. are disproportionately affected by HIV, STIs, COVID-19, intimate partner violence, stigma, and poor maternal and child health outcomes. These inequities can accumulate across the lifespan, undermining overall health outcomes. Check out the Effi Barry Training Institute's 3 part series webinar, “Black Women's Health Across the Lifespan” Part 1:Black Adolescent & Young Women: Sex Positivity and Healthy Relationships Part 2: Black Women and Sexual and Reproductive Health Part 3: Promoting Health and Wellness for Black Older Women

This week's episode of The Prison Post Policy Hour with CROP Organization's Director of Business Development, Ken Oliver features Marlene Sanchez, Deputy Director of The Ella Baker Center. Marlene is a proud San Francisco Native, Chicana, movement leader, organizer, and a formerly incarcerated woman. Marlene came to community work at the age of 15 looking for employment and a way out of streets and the juvenile justice system. She was hired as a community health outreach worker, providing HIV/STD education and harm reduction supplies and love to hundreds of young women who lived and worked in the underground street economies of San Francisco. She has since stepped into leadership at the Young Women's Freedom Center, Communities United for Restorative Youth Justice (CURYJ), and recently served as the Interim Executive Director of Alliance for Girls, an organization she helped found. Marlene is a founding member of All of Us or None (AOUON); a movement building group working to restore the rights of – and fight against the discrimination of – incarcerated and formerly incarcerated people. #CROPOrganization #WorkingTogethertoRestoreLives #ThePrisonPost #ThePrisonPostPolicyHour #TheFourPillarsofSuccessful Reentry #TheEllaBakerCenter

Hailey Stout currently works in the field of HIV/STD prevention. She earned a bachelor's degree in Human Environmental Sciences and a master's degree in Human Development and Family Studies from the University of Missouri--Columbia. In this episode, she shares her broad variety of professional experiences so far, from business to working with military families to the Peace Corps to her current role. (Please note that sexual violence and military combat are discussed in this episode.)

Full Circle Radio with Ms. Wanda - Empowerment through Conversation: Original Air Date: 2/23/2019 Hear my conversation with Yemi Lawrence and Foxy Robinson, medical students/health care providers at the Imani Clinic. Did you know the Imani Clinic provides health services free of charge to the Sacramento Community? Some of the many services they provide: full physical exams, mental health screenings, prescription refills, HIV/STD testing, preventative health services and more. Email the show at: Fullcircle975@gmail.com Like, share and follow the show on Social Media: Facebook: https://www.facebook.com/Full-Circle-975-131396301044120/?eid=ARDhouJJunlpb7dFOodvfQUeInFqD7Wu0d3SXfWoDa_AaY0Bma6eMHTFpS-PIq-F6vjp8wH7JxHs6vc3 Instagram: Full_Circle975

Session 90 Dr. Philip Chan is an academic Infectious Diseases physician at Brown University in Rhode Island. He has been out of training now for about 8 years. He talks about his typical day, why he chose this specialty, the training path, and an inside look into this field. Meanwhile, be sure to check out all our other podcasts on MedEd Media Network. [01:22] Interest in Infectious Disease Philip recalls being interested in Infectious Diseases (ID) back during undergrad. With a Major in Microbiology, he was basically interested in bacteria, viruses, infections, and how to solve such problems. Although Philip's dad is a cardiologist, he was already interested in fixing things at an early age. So he went to college majoring in Engineering. Then he realized he wanted to go to medical school so he shifted to Biology. However, he thought it was too generic so he then changed to Microbiology, specifically focusing on genetic engineering. [02:40] Traits that Lead to Becoming a Good Infectious Diseases Physician Philip says you've got to have the ability to think through a problem from top to bottom. You also have to have a particular attention to details. He advises medical students, especially early in their career, is to think about a problem in a timeline. You have to be able to put things together in a timely fashion and think through the different problems and problem-solving critically. He initially got into the field of HIV early on in his career mainly due to the research aspect of it. But as he progressed, he had gotten so much interested in the intersection of HIV, social justice, and health disparities. A lot of his work is presently focused on public health at the community level and engaging populations across their state. [04:20] Other Specialties of Interest During medical school, Philip found everything to be interesting. He loved his surgical rotations as well as OB-GYN, Medicine, Pediatrics, and Oncology. But when he got to residency, he felt he was fully committed to Infectious Diseases. He did consider Oncology due to the genetic research he did at that time. But he eventually landed on his current specialty and he's happy he did. What he likes about ID is that it touches every part of the body. There's a broad overlap of lots of other fields and disciplines. You can actually cure a lot of infection. A lot of medicine now is managing chronic diseases. That's fine. But one thing that appealed to him about infections is that you can cure a majority of them. You can make people 100% back to normal. "A lot of medicine now is managing chronic diseases... but one thing that appealed to me about infections is that you can cure a majority of them." [06:00] Types of Patients Philip categorizes patient care in two types. He does consult in the hospital where he'd be dealing with "bread and butter infectious diseases" These include endocarditis, osteomyelitis, diabetic skin, and tissue infections. They also treat a spectrum of all other infections from malaria to TB and to many other sorts. Moreover, the outpatient side has become more of his "bread and butter." This includes HIV care. He started the prep/prophylaxis clinic at their site. He also runs their STD clinic. He didn't receive enough training in these through fellowship and residency. But the outpatient ID care has taken a lot of his time now. About a third of the time, there are clear culture data to help guide the decisions. Then a third of the time, they don't have culture data. Cultures may not be accurate, negative, or they're not drawn correctly. Then there are also lots of bugs that don't grow. Philip believes that about a quarter of the time, they're shooting dark and making their best guess. Then they're just guided by other aspects of the clinical patients. The other third of their time, they deal with random things that they get called for. Majority of the cases would be fever. For instance, there's a rising blood count. Others would be taking random questions that may be unclear to the primary care team. 10% of the time would be people getting diseases from other countries like malaria, TB, etc. And a small percent of that time, they're able to nail the diagnosis of some really random diseases. They give them the appropriate antibiotics and cure them. "You've given the appropriate antibiotics and you cure them. That's one of the greatest feelings in ID." [09:40] Is His Job Just Like the TV Show House? Funny how Philip thinks that none of it does look anything like his job. 1 out of every 10 patients, he sees the complete mystery and you try to piece things together. One thing they really love to do as ID doctors is to dive into the social history. This includes the person's demographics and how you frame them epidemiologic-wise. And just to be clear, there is no housebreaking involved. "For many parts of medicine, the social history doesn't necessarily matter quite as much. But in ID, the social history can really be everything." [10:45] Academic vs. Community Setting Philip believes there are pros and cons to each. Basically, it's about what you like to do. In private practice, there's incredible flexibility especially if you work for yourself. You can make much more in the private world depending on what you do. He describes his career as being very academic and research-oriented. He's also the PI of several NIH grants and other grants, which you can't do in the private world. For academic ID careers, you can get involved in research and public health. You have the chance to get involved in lots of other different committees and leadership roles and stewardship. You can work for the Department of Health. "There's a lot of other opportunities in the career of ID to really spread out." [11:50] Doing Research without a PhD Philip is doing a ton of research at a major Ivy League institution, yet he doesn't have a PhD. This is concrete proof that it is possible to do research without that PhD. After his undergrad, he got a masters in Genetics. So he has some research experience that he has built on. What he recommends to students is that if you're really interested in research, really collaborate. One of the keys to successfully writing NIH grant is he always leads the grant with a PhD person. The NIH loves this as there are two different complementary skill set – one a clinically oriented researcher and the other a PhD-driven researcher. [13:00] Typical Week Philip holds clinics on Thursday and Friday afternoons. For about 4-8 weeks of the year, he does inpatient service time where he sees most of the bread and butter disease cases. Then the rest of this time is spread out running various research and the programmatic aspects of what they do. He's spread across various institutions, pushing different agendas related to HIV and other STDs. [14:00] Doing Procedures and Taking Calls Compared to other fields, ID is a less procedure-driven field. But there are a lot of things you can do, which are quite parallel to what an internist does. For instance, they do lumbar punctures, thoracentesis, and other procedures. There are other physicians who feel comfortable doing biopsies.  Nevertheless, they routinely take cultures. "Compared to other fields, ID is a less procedure-driven field." According to Philip, the beauty of this field is that there's not many emergencies where you have to go into the hospital ever. Hence, this gives them a very good quality of life in terms of taking calls. He personally takes calls a couple of months where he has to answer phones through the night. However, for academic institutions, there's a fellow who takes all the calls. And if there's something they can't answer, they then refer it to the attending. And this happens to him only about 1-2x  a year. For a lot of the calls, they'd usually give the patient antibiotics and see them in the morning for evaluation. Philip says he has a good work-life balance. His wife works full-time so he actually does a lot of the childcare in their household especially in the evenings. Although you have flexible time, you have to put in the time to be successful. But you can be flexible in terms of how time is managed. He makes sure he exercises everyday. "As an academic ID physician, you have the flexibility of your time." [16:55] The Training Path and Competitiveness Infectious Diseases is a fellowship after internal medicine residency. You go through the traditional 3-year internal medicine residency. In general, you go through a two-year clinical fellowship after that. There are numerous variations such as research-oriented fellowships combined clinical research fellowships for 3+ years. Given that ID is an especially research-driven field, there are lots of places that combine clinical and research together. The typical pathway is two years of ID fellowship. A number of his colleagues come from Med-Peds residencies to do Adult ID and Pediatric ID fellowship over 3-4 years as well. Pediatric ID is a specialty so you can go from a pediatric residency into a pediatric ID fellowship. The top programs in ID tend to be competitive but there is not as competitive per se as Cardiology or GI. To be competitive, you should do well in residency as a rule of thumb. Be involved in something that really demonstrates your interest. ID is very diverse as there are a lot of people from various backgrounds and experiences that are interested in the field. For instance, there are people interested in infection control, antibiotic management, international health, HIV/STD pathway, etc. So try to explore these through residency. Do research or other projects with a mentor to really show and demonstrate your interest. Or to find out if this is really something you're interested in and that you want to continue this pathway. Just do something outside of your normal residency duties. If you're interested in academic medicine, you can get involved in some grants or publications. [20:45] Subspecialty Opportunities There are various routes to become certified in HIV care. One is to do a fellowship in Infectious Diseases. As an internal medicine doctor, there are certification programs where you can become a certified medicine physician in HIV care. This is generally a one-year fellowship. Once you've become specialized, there isn't any "next step" in terms of specialty. Those that really take the next level are research experts. These are people who have developed research expertise in drug resistance, for instance or a neurological complication-related to HIV/AIDS. Usually, these are people who have done research on a specific topic of HIV. These are world-renowned experts in a specific aspect of HIV. Within your typical ID fellowship program, there are usually no specific tracks where you can get certified in. Usually, it's based on where you spend your time on. There are elective months as well as clinical care. A lot of these are self-directed and self-driven. There are programs, workshops, and courses being offered at academic institutions where you can start to develop specific interest and focus within aspects of infectious diseases. "Most of what happens in how one develops one's interest and expertise, within infectious diseases, is based on where you spend your time." Alternatively, the people that develop expertise in meningitis or fungal inspection or STDs are people who have developed programs and research portfolios around those different topics. [24:15] Bias Against DOs One of Philip's mentors is a DO who runs infectious control at Rhode Island Hospital. He routinely calls him for pieces of advice. He knows other fantastic mentors who are DOs. "It's less about the degree after your name and more about what you make of yourself and how your career transpires." [25:10] Working with Primary Care and Other Specialties Philip also provides primary care himself to his HIV positive patients. The way medicine has gone, as he puts it, is that everything is subspecialized that it's so impossible to be good at everything. You can't just keep up with every single aspect of literature or every single disease. He found that through the years, he has become less comfortable managing aspects of diabetes and primary prevention related to cardiovascular disease. Moreover, there are some diseases like HIV that if you engage all primary care physicians, we would all have the potential to make huge strides in addressing the HIV epidemic. So they're trying to engage the primary care community in assisting patients with HIV testing and STD testing. Other specialties ID physicians work the closest with include internists/primary care and hospitalist internists. [27:22] Special Opportunities Outside of Clinical Medicine There are tons of opportunities for ID physicians to get involved. He has colleagues across the world who work internationally. There are people who provide care at international sites and those who consult with NGOs and the WHO. Nationally and locally, there are many health departments across the country that have consulting physicians. Some even have full-time physicians for infectious diseases within public health. Personally, Philip consults part-time for the Department of Health aspects related to HIV and STD. There are also opportunities at other outpatient health centers. Some of his colleagues provide consulting services related to Hepatitis C treatment, HIV care, and other aspects of ID care to community health centers, NGOs, etc. A lot of community-based organizations have medical director roles related to substances treatment, AIDS service organizations, STD clinics, etc. [28:45] What They Don't Teach in Medical School For Philip, leadership was something he had to learn on the fly. He currently manages a team of over a dozen people. The business aspect is something they don't teach you in medical school, as well as how to manage people and how to be a leader. They train you very well throughout medical school and residency to be a clinician. But for basic business/leadership/managing skill was something he had to learn on the fly. This was something he had to do everyday. That being said, it was something he wished he had formal training with given his current positions. What he has done though was to find key mentors or people who have been through this time and time again. He'd lean on them heavily and ask them questions about how to navigate different situations. "Seek out a couple of key trusted people that you can ask confidentially some tricky situations if you ever find yourself in them." [30:50] The Most and Least Liked Things Philip has gravitated more into the preventative side of infection, which was something he didn't anticipate through his training. He started their HIV preexposure prophylaxis program. He sees a lot of people that are at risk of HIV and one of his jobs is to keep them negative. He enjoys interacting with young HIV positive people. Preventative care wasn't something he saw doing 10-15 years ago. But he has now found this to be the most enjoyable aspect. "I feel like I do a lot of education, counseling, teaching, and mentorship to my patients – guide them through difficult situations, mostly, but not all related to their health." On the flip side, what he likes the least about his practice is the administrative aspect that can become sometimes overwhelming. At some point, the administrative side of medicine may start to weigh heavily on your career. So just set some clear boundaries and structures to help manage that time. In fact, Philip just sat on a panel for physician burnout and found that the EMR is one of the number of causes for physician burnout. [33:10] Major Changes in the Future Philip says that for those considering careers in HIV specifically, is to consider places where HIV is affecting people most, including the deep south. A lot of money and resources are now being redirected to such places where HIV is hit the hardest. In terms of HIV cure, Philip sees an optimistic future in the fact that it can be done. a couple of patients now have received bone marrow transplants with HIV mutations to make them resistant to HIV infections. And when implanted with a bone marrow transplant, these people can now be cleared of HIV. There could still be remnants of HIV but people in the field are considering this as functional care. However, this is not something really applicable to the general HIV population. Reason being is that in order to get a bone marrow transplant, you have to destroy one's immune system. Bone marrow transplant is for those with leukemia and other blood-borne cancers. Also, there's a 25% mortality rate with bone marrow transplants. And you wouldn't want to risk that percentage for putting HIV medication that can keep you controlled for life. All this being said, it has the potential to cure HIV. Ultimately, Philip would still have chosen to be an ID doctor if he had to do it all over again 110%. His advice to students is to do it early. It's a fantastic career and he's 100% glad he did it. There are tons of opportunities with some overlaps with international careers, public health, and public policies. "Try to explore a career in ID especially if you're interested in public health, social determinants of health, addressing health disparities." Links: MedEd Media Network

This is a conversation about public health, HIV, immunization and billing with Phil Talley, Program Coordinator, and Jeffrey Erdman, Assistant Director for Programs and Compliance, both with the Illinois Public Health Association.  “We know that definitely in rural areas and in particular in the southern part of the United States, HIV cases are more heavily concentrated than we see throughout the rest of the nation.”   Philip Talley is a licensed insurance professional with more than 25 year of experience in various aspects of health insurance. He joined the Illinois Public Health Association in 2014 to help manage the Immunization Billing Project which has been featured on the CDC’s website as a “Billing Project Success Story”.  Mr. Talley is now focused on the IPHA’s HIV Third-Party Billing Project, assisting local public health departments and community-based organizations with building their capacity to bill third-party payers for HIV testing and other HIV prevention services.   “Having an efficient successful billing system will also enable providers to expand and diversify their scope of services and be able to provide more valuable services, and reach perhaps communities that they’re not currently serving.”  Jeffery M. Erdman, a nationally recognized HIV prevention specialist, evaluator, and behavioral researcher, currently serves as the Assistant Director for Programs and Compliance for the Illinois Public Health Association.  Mr. Erdman and colleagues have developed and implemented a nationally honored group HIV prevention intervention for young African-American men who have sex with men, “Very Informed Brothers Engaged for Survival (VIBES),” which has been presented at numerous conferences, including the 2005 United States Conference on AIDS in Philadelphia and the 2007 United States Conference on AIDS in Palm Springs, CA.    Mr. Erdman and colleagues have also conducted research into the use of new technologies and HIV/STD prevention among adolescents. This work has been presented at numerous conferences, including the 2011 United States Conference on AIDS in Chicago.  Currently, Mr. Erdman and colleagues are engaged in work to implement third-party billing for HIV and immunization services among local health departments and other healthcare providers.    In addition to these accomplishments, Mr. Erdman has been honored with awards from the Illinois Department of Public Health, the American Association for World Health, and the Society of Professional Journalists, and he has been published in various journals and periodicals for work he completed as a research specialist at IDPH, Northwestern University and the Edward Hines Jr. Veterans Administration Hospital.  To contact Phil or Jeff, please send an email to insurancebilling@ipha.com.  You can also check out their website they mentioned:  www.ipha.com 

In this episode, we spoke with Dr. Ralph DiClemente, Chair of the Department of Social and Behavioral Sciences, about his research and experience creating interventions for vulnerable populations around the world.  Dr. DiClemente was trained as a Health Psychologist at the University of California, San Francisco where he received his PhD in 1984 after completing a ScM at the Harvard School of Public Health.  He earned his undergraduate degree at the City University of New York. Dr. DiClemente’s research has four key foci: Developing interventions to reduce the risk of HIV/STD among vulnerable populations Developing interventions to enhance vaccine uptake among high-risk adolescents and women, such as HPV and influenza vaccine Developing implementation science interventions to enhance the uptake, adoption and sustainability of HIV/STD prevention programs in the community Developing diabetes screening and behavior change interventions to identify people with diabetes who are unaware of their disease status as well as reduce the risk of diabetes among vulnerable populations. He has focused on developing intervention packages that blend community and technology-based approaches that are designed to optimize program effectiveness and enhance programmatic sustainability. Dr. DiClemente is the author of ten CDC-defined, evidence-based interventions for adolescents and young African-American women and men. He is the author of more than 540 peer-review publications, 150 book chapters, and 21 books. He serves as a member of the Office of AIDS Research Advisory Council. To learn more about the NYU College of Global Public Health, and how our innovative programs are training the next generation of public health leaders, visit publichealth.nyu.edu.  

Pozitively Dee discussion 4 pm MST, 3 pm PST, 5 pm CT and 6 pm EST call in and join the talk 515-605-9375 or listen online at bolgtalkradio.com at the above times. My featured guest will be JL King who in 2004 spoke about his first book (On The Down Low) and his life on the Oprah Show. DL King has since then published many books and started a publishing company. Mr. King is a bestselling author who is one well-known black author in the world about sexuality and men he's a motivational speaker, play-write of 9 plays, and an activist for HIV/STD. We will discuss what he has been doing the last 13 years since the first book came out a book that shocked the world with his talk of men sleeping with men and keeping it a secret.

On the June 3 Boomer Generation Radio show, Rabbi Address's guests, Rabbi Sue Levi Elwell, and Nurit Schein, director of the Mazzoni Center, a health center serving the LGBT community, open the conversation with a discussion of aging issues as they affect the LGBT community. In the second half of the program, sponsored by not-for-profit retirement community operator Kendal Corporation, Rabbi Address welcomes Alice Moore, a nurse educator and lead trainer for Kendal, and Neil Beresin, the national program manager for Vitalize 360, a senior coaching and assessment process that uses art and science to promote optimal wellness for successful aging. The program combines an award-winning, innovative wellness coaching program with the power of information derived from a scientifically-grounded assessment system. About the guests Rabbi Sue Levi Elwell, Ph.D. [caption id="" align="alignleft" width="114"] Rabbi Sue Levi Elwell, Ph.D.[/caption] For more than three decades, Rabbi Sue Levi Elwell, Ph.D. has been exploring, teaching and writing about spirituality, and working towards creating and sustaining healthy and open-hearted communities. She has served congregations in California, New Jersey and Virginia, and has taught at the University of Cincinnati, UCLA, and LaSalle University. Elwell edited The Open Door, the CCAR Haggadah (2002), served as the poetry editor and member of the editorial board of the award winning The Torah: A Women's Commentary (2008), and as one of the editors of Lesbian Rabbis: The First Generation (2001). The founding Director of the Los Angeles Jewish Feminist Center, Elwell recently retired from the Union for Reform Judaism where she has served as the Director of the Pennsylvania Council and Federation of Reform Synagogues of Greater Philadelphia from 2001-2008. A Senior Rabbinic Fellow of the Shalom Hartman Institute in Jerusalem, she continues her studies through the Institute for Jewish Spirituality. A lifelong Reform Jew, Elwell is the mother of two grown daughters. She lives in Philadelphia with her partner, Nurit Shein, who directs The Mazzoni Center, Philadelphia's pre-eminent LGBT health center.     Nurit Schein [caption id="" align="alignleft" width="100"] Nurit Schein[/caption] Since 1995 Nurit Shein has been at the helm of Mazzoni Center, overseeing its operations and departments in primary health care, mental and behavioral health, and LGBT legal services, as well as HIV/STD testing, food bank and housing subsidies for families and individuals affected by HIV, support groups, outreach and education programs A native of Israel, Shein served as a career officer in the Israeli Army, working in intelligence, women's corps, and as commander of the army's education corps before retiring as a colonel. Prior to her arrival in Philadelphia she was the director of programs for the L.A. Gay and Lesbian Center. Contact Nurit via email at: nshein@mazzonicenter.org       [caption id="" align="alignleft" width="112"]Alice Moore[/caption] Alice Moore, LNHA, RN, MPA is Nurse Educator for Leading Nurses. She has more than 25 years of experience in a variety of positions in health care administration, clinical bedside nursing, and public health policy. She has had extensive experience with training and education at multiple Area Health Education Centers (AHEC), universities, and numerous projects for state agencies, including home- and community-based implementation of assessment and quality assurance programs using standardized assessment tools and qualitative outcomes. She has special interests in data-driven outcomes related to educational competency working with hands-on staff and development of online testing data to guide curriculum development and application. In her current role with Leading Nurses, she works with participants to enhance their leadership and management skills in the implementation protocols to improve the effectiveness of pressure ulcer prevention, improvement of activities of daily living, pain and mood disorder identification and management. [caption id="" align="alignleft" width="111"] Neil Beresin[/caption] Neil Beresin, M.Ed., BA, has a diverse background in psychology and education, and experience in geriatric case management and family crisis intervention. He was Regional Director for the Pennsylvania Restraint Reduction Initiative (PARRI) from 1996 to 2006. In his current role as National Program Manager of COLLAGE, The Art and Science of Aging®, Neil manages communication and promotion, program development, and member education and services.       Boomer Generation Radio airs on WWDB-AM 860 every Tuesday at 10 a.m., and features news and conversation aimed at Baby Boomers and the issues facing them as members of what Rabbi Address calls “the club sandwich generation.” You can hear the show live on AM 860, or streamed live from the WWDB website.   Subscribe to the RSS feed for all Jewish Sacred Aging podcasts. Subscribe to these podcasts in the Apple iTunes Music Store.

Ladies you CANNOT afford to miss today's Conversations with Dr. D Ivan Young. It may save your life. It's 2013 and HIV is still on the rise, especially with African American men on the down low. Blacks/African Americans continue to be disproportionately affected by HIV infection. The estimated rate of new HIV infections among blacks/African Americans (68.9) was 7.9 times as high as the rate in whites (8.7).    Tyvance Credit joins Dr. D to explore this controversial subject. Tyvance has been a key figure in the fight against the HIV/STD phenomenon in the Houston area for 15 years.  Tyvance has tested more than 100,000 people, diagnosed at least 5,000, and linked about 70% of them to care. In his dedication to the cause, he has been known to pop the trunk and test people on the back of the car! He founded the first internet program (B.O.I.S.) to outreach to people to prevent them from becoming HIV Positive. In 2012, he launched "The Tyvance Experience" to address the needs of women and their common need of self validation, appreciation, and confidence to continue being the back bone of the family and relationships.    You won't want to miss this enlightening conversation!   To submit show ideas, comment or be considered as a featured guest, email julia@divanyoung.com.

Leif Mitchell discusses use of the internet, social media tools and other popular technologies as means for behavioral change in the HIV/STD community.